Annett Kallies
Erlangen, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Reply to: "Chemoradiotherapy in Pancreatic Cancer: Toward Precision Oncology," "Key Methodological Considerations in the Interpretation of the CONKO-007 Trial," and "Chemoradiotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer".
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 02, 2026
Erratum: Benefit of Chemoradiotherapy Versus Chemotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer: The Randomized CONKO-007 Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 08, 2026
Benefit of Chemoradiotherapy Versus Chemotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer: The Randomized CONKO-007 Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 13, 2025
Change in Quality of Life in Patients with Advanced Rectal Cancer Between 2010 and 2022.
Journal: Healthcare (Basel, Switzerland)
Published: September 13, 2024
The health-related quality of life of sarcoma patients treated with neoadjuvant versus adjuvant radiotherapy - Results of a multi-center observational study.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: June 08, 2023
Impact of COVID-19 on Quality of Life in Long-Term Advanced Rectal Cancer Survivors.
Journal: Healthcare (Basel, Switzerland)
Published: May 03, 2023
Substantial Impairment of Quality of Life during COVID-19 Pandemic in Patients with Advanced Rectal Cancer.
Journal: Healthcare (Basel, Switzerland)
Published: July 05, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026